Continuous versus intermittent oral administration of levodopa in Parkinson's disease patients with motor fluctuations: A pharmacokinetics, safety, and efficacy study.
C Warren OlanowMargherita TortiKarl KieburtzMika LeinonenLaura VaccaPaola GrassiniAdam HellerEphraim HellerFabrizio StocchiPublished in: Movement disorders : official journal of the Movement Disorder Society (2019)
Continuous oral delivery of l-dopa/carbidopa was associated with less plasma variability and reduced off time in comparison to standard intermittent oral l-dopa/carbidopa therapy. © 2019 International Parkinson and Movement Disorder Society.